TAKHZYRO
Google image searchProduct monograph
Active ingredient
lanadelumab, 300 MG/2 ML
DIN: 02480948
Dosage form(s): SOLUTION
Route(s) of administration: SUBCUTANEOUS
Description: SINGLE USE VIALS
Schedule: Prescription / Schedule D
Company: TAKEDA CANADA INC
Date: 12-JAN-2022
ATC:
- B06 — OTHER HEMATOLOGICAL AGENTS (ATC, ATC/DDD, )
- B06A — OTHER HEMATOLOGICAL AGENTS (ATC, ATC/DDD)
- B06AC — Drugs used in hereditary angioedema (ATC, ATC/DDD)
- B06AC05 — LANADELUMAB (ATC/DDD)
Reference brand drug: Takhzyro
External Links for Takhzyro
Search on Google
Takeda Canada Inc
Go to Takeda website to see drug product details. Sometimes you can find takhzyro photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.